FDA wants public input before regulating AI-enabled medical tools
The U.S. Food and Drug Administration has released a discussion paper seeking public input on how to regulate AI-enabled and generative AI-based medical tools. The agency is gathering feedback on risk assessment, premarket evaluation, postmarket monitoring, and a potential voluntary model card program to inform a more flexible regulatory framework.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.